ArticleFrontiers in oncology2025
Preoperative prognostic assessment using intratumoral and peritumoral adipose tissue radiomics derived from contrast-enhanced CT in cT3-4 gastric cancer.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Exploring the value of contrast-enhanced computed tomography (CECT) based radiomics features from intratumoral and peritumoral adipose tissue (PAT) in predicting early recurrence (ER)after gastrectomy in patients with cT3-4 gastric cancer (GC). Materials and methods: This retrospective study involved patients with cT3-4 GC who underwent preoperative CECT. The radiomics features of tumor and PAT were separately extracted from the CT venous phase images using the Pyradiomics package. The radiomic score (radscore) was computed for each patient by integrating LASSO regression-selected radiomic features, weighted according to their respective coefficients. The GC location, longest diameter, maximum thickness, cT stage and cN stage determined by preoperative CT were also evaluated. Univariate and bivariate analyses using the Cox regression model were performed to evaluate factors affecting ER. The Kaplan-Meier method was used for the analysis of ER-free survival. Results: A total of 184 consecutive cT3-4 GC patients were enrolled in this study. Bivariate Cox regression analyses demonstrated that radscore and cT stage emerged as independent predictors of ER in all parameters. Radscore-based stratification showed a marked difference in the ER rates between high-risk patients (radscore ≥ -0.66) and low-risk patients (65.9% vs. 3.2%; log-rank p<0.001). Similarly, cT4 stage patients had markedly higher ER rates than cT3 stage patients (53.5% vs. 22.1%; log-rank p<0.001). Conclusion: The integrated radscore combining intratumoral and PAT features emerged as an independent prognostic predictor for ER in cT3-4 GC, offering quantitative biomarkers to optimize neoadjuvant therapy selection and postoperative surveillance intensity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.